Treatment Algorithms in Melanoma: Past, Present, and Future

Access Course

 

882627.jpg?interpolation=lanczos-none&resize=300:225Watch these experts discuss updates in the use of immunotherapy in melanoma, including novel approaches and immunotherapy in the adjuvant setting.

 

This activity is intended for oncologists, dermatologists, and pathologists.

 

The goal of this activity is to discuss both the practicalities of using checkpoint inhibitors in melanoma and the emergence of new immunotherapeutic strategies.

 

 

Approximate Time to Complete: 30 minutes

 

Credit Available: Nov. 13, 2017 - Nov. 13, 2018

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the mechanisms of action of approved immunotherapeutic regimens for the management of metastatic melanoma
  • Have increased knowledge regarding the mechanisms of action of investigational immunotherapeutic agents alone or in combination
  • Have increased knowledge regarding the strategies to address challenges in the management of metastatic melanoma
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 0.50
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 0.50